EU Needs ‘Agile & Enabling Ecosystem’ To Address Decline In Clinical Trials

 
• By Ian Schofield
  
Red arrow descending
Europe's pharma industry wants action to address the decline in clinical trial activity (Shutterstock)

More from Clinical Trials

More from Geography